News About: Goverment
KFDA to strengthen ADR reports
The Korea Food and Drug Administration says the nation’s adverse drug reaction system will be further upgraded as pharmaceutical manufacturers will be obliged to employ one or more drug safety managers from October 18...
Vice chairman PhRMA arrives in Seoul
The International Regulatory Committee vice chairman of Pharmaceutical Research and Manufactures of America (PhRMA) visited Seoul to share ideas with his Korean counterpart on common technical document (CTD) and the n...
Academia calls for careful approach over economic effectiveness of medicines
The local academia circle has demanded the government revise the current method of evaluating conventional medicines as about 20 experts are available only in universities.
“Considering the shortage of professional...
KFDA commissioner backs safety and efficacy of combined generic medications
The safety and efficacy of combined generic medications may be demonstrated by a comparative dissolution test only, according to the Korea Food and Administration.
In a parliamentary audit, the KFDA’s commissioner ...
Park Geun-hye calls for further price cut of new drugs after patent expiration
During the recent parliamentary inspection of the Ministry of Health, Welfare and Family Affairs, Rep. Park Geun-hye of the governing Grand National Party (GNP) stressed the need for slashing the price of new drugs wh...
Song named as head of HIRAFormer Vice Health Minister Song Jae-sung, has been named the new president of the Health Insurance Review and Assessment Service.
Cheong Wa Dae is scheduled to announce his ...
|
Donwha to recall antibiotic Gatiflo
Dongwha Pharm has a plan to recall all products of Gatiflo from wholesalers and pharmacies (gatifloxacin) between October 7 and 20.
Gatiflo is an antibiotic that has been associated with hyperglycemia and hypoglyce...
Government to opt for EP regulations over biosimilar products
The Korea Food and Drug Administration is considering adopting the European regulations and guidelines in the process of screening biosimilar products.
The health regulator says the EP regulations are less stringen...
Health ministry reaffirms rebate banThe government will stamp our pharmaceutical firms offering rebate provisions to encourage fair competition, Health and Welfare Minister Jeon Jae-hee said on September 6.
Jeo...
|
Deregulation plan under fireThe government’s plan to improve the corporate environment and develop the services industry invited strong criticism from opposition lawmakers.
During a parliamentary inspec...
|
